Actigall and Nonspecific back pain - a phase IV clinical study of FDA data

Summary:

Nonspecific back pain is reported as a side effect among people who take Actigall (ursodiol), especially for people who are female, 40-49 old, also take Prilosec, and have Oedema peripheral.

The phase IV clinical study analyzes which people have Nonspecific back pain when taking Actigall. It is created by eHealthMe based on reports of 2,122 people who have side effects when taking Actigall from the FDA, and is updated regularly.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.

What is Nonspecific back pain?

Nonspecific back pain (back pain without any serious problem) is found to be associated with 4,199 drugs and 4,787 conditions by eHealthMe. Check the latest studies of Nonspecific back pain.

On Jun, 12, 2026

2,122 people reported to have side effects when taking Actigall.
Among them, 59 people (2.78%) have Nonspecific back pain.

Could Actigall cause Nonspecific back pain?

Among these 59 people:

What is the gender of people who have Nonspecific back pain when taking Actigall? *

female: 68.52 %
male: 31.48 %

What is the age of people who have Nonspecific back pain when taking Actigall? *

What are other drugs people take besides Actigall? *

What are other side effects people have besides Nonspecific back pain? *

Fatigue (feeling of tiredness): 19 people, 32.20%
Dyspnea (difficult or laboured breathing): 18 people, 30.51%
Abdominal Pain: 17 people, 28.81%
Nausea (feeling of having an urge to vomit): 17 people, 28.81%
Weakness: 16 people, 27.12%
Dizziness: 15 people, 25.42%
Chest Pain: 13 people, 22.03%
Oedema Peripheral (superficial swelling): 12 people, 20.34%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 12 people, 20.34%
Confusional State: 12 people, 20.34%

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 11 people, 18.64%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 9 people, 15.25%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 8.47%
Pain: 5 people, 8.47%
Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 6.78%
Nausea (feeling of having an urge to vomit): 4 people, 6.78%
Osteoporosis (bones weak and more likely to break): 4 people, 6.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.08%
Cystic Fibrosis (disease of the secretary glands): 2 people, 3.39%
Hepatitis C: 2 people, 3.39%

* Approximation only. Some reports may have incomplete information.

Do you take Actigall and have Nonspecific back pain?

- Check whether Nonspecific back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actigall:

Actigall (2,162 reports)

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nonspecific back pain:

Nonspecific back pain (4,199 drugs)

Browse all the conditions that are associated with Nonspecific back pain:

Nonspecific back pain (4,787 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Actigall) and Actigall (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.